Chicago, IL, August 23, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical, quality and compliance, medical information, and pharmacovigilance services and solutions...
ProPharma Group Named Top 10 CRO 2022 by Pharma Tech Outlook A Customer-Centric Approach to Clinical Research Solutions ProPharma Group is honored to be named Top 10 CRO 2022 by Pharma Tech Outlook...
ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards: ProPharma Group is honored to be awarded "Best Pharmaceutical Regulatory & Compliance...
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the acquisition of M Squared Associates (M2), an industry leading clinical, regulatory and quality consulting firm...
Planet Pharma ranked as the fifth Largest Life Sciences Staffing Firm in the US Chicago, IL (December 9, 2021) — Planet Pharma, part of The Planet Group and a global company specializing in staffing...
ProPharma Group, a portfolio company of Odyssey Investment Partners, is the global, independent, single-source provider of regulatory, clinical and compliance services serving pharmaceutical,...
ProPharma Group Announces the Acquisition of iSafety Systems: ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of iSafety Systems. Headquartered in...
NDA Partners President Earle Martin announced today that Cristina Giachetti, PhD, former Deputy Director of Diagnostics at the Bill and Melinda Gates Foundation, has joined the firm as an Expert...
RALEIGH, NC, December 6, 2023 – ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and compliance services...
RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
$50m investment and rebrand unveiled at J.P. Morgan Healthcare Conference as part of new global growth strategy. RALEIGH, NC, January 9, 2023: ProPharma Group – the end-to-end, global provider of...
ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting...